Table 1 Comparison of included patients with and without catheter-associated bacteriuria (CA-bacteriuria)
Variables | Patients | ||
|---|---|---|---|
CA-bacteriuria (n = 20; 31.2%) | No CA-bacteriuria (n = 44; 68.8%) | p. value | |
Demographics | |||
Age (years)a | 71 ± 12.9 | 63.7 ± 15.5 | 0.06 |
Male/Female (number) | 8/12 | 37/7 | 0.001 |
Medical past history | |||
Chronic kidney disease (%) | 4 (20%) | 5 (11.4%) | 0.44 |
Diabetes mellitus (%) | 3 (15%) | 4 (9.1%) | 0.66 |
Primary disease | |||
Acute renal failure (%) | 2 (10%) | 1 (2.3%) | 0.23 |
Cardiac arrest (%) | 1 (5%) | 3 (6.8%) | 1.00 |
Coma (%) | 4 (20%) | 7 (15.9%) | 0.73 |
Postoperative care (%) | 1 (5%) | 3 (6.8%) | 1.00 |
Respiratory failure (%) | 2 (10%) | 1 (2.3%) | 0.23 |
Sepsis (%) | 5 (25%) | 17 (38.6%) | 0.39 |
Shock (%) | 4 (20%) | 11 (25%) | 0.75 |
Traumatism (%) | 1 (5%) | 1 (2.3%) | 0.53 |
ICU Data | |||
Length of stay (days)a | 11.3 ± 10.1 | 11.3 ± 8.8 | 0.99 |
Admission weight (Kg)a | 82.9 ± 25.7 | 76.4 ± 24.7 | 0.34 |
BMI (kg/m2)a | 30.5 ± 9.5 | 30.6 ± 30.2 | 0.98 |
SAPS II scorea | 50.3 ± 29.2 | 50.3 ± 21.8 | 0.69 |
Anti-infective therapyb | |||
Prior to urinary catheterization (%) | 6 (30%) | 34 (77.3%) | 0.0006 |
During patient follow-up (%) | 10 (50%) | 35 (79.5%) | 0.04 |
Mean duration (days) ab | 6.45 ± 1.72 | 7.68 ± 1.05 | 0.55 |
Complications | |||
Death (%) | 1 (5%) | 5 (11.4%) | 0.65 |
Mechanical ventilation (%) | 8 (40%) | 22 (50%) | 0.59 |
Non-invasive ventilation (%) | 10 (50%) | 27 (61.4%) | 0.42 |
Vasoactive amine (%) | 9 (45%) | 16 (36.4%) | 0.58 |
Acute renal failure (%) | 5 (25%) | 9 (20.5%) | 0.74 |
Dialysis (%) | 3 (15%) | 6 (13.6%) | 1.00 |
Urinary catheterization | |||
100% silicon catheter (%) | 16 (80%) | 38 (86.3%) | 0.71 |
Silicon-coated-latex catheter (%) | 4 (20%) | 6 (13.7%) | 0.71 |
Mean duration of catheterization (days) a | 6.45 ± 0.94 | 6.98 ± 0.73 | 0.89 |